<dfn id="9suha"></dfn>
<dfn id="9suha"></dfn>
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Barrow CJ, et al. Aspergillus species, cyclic dimeric dipeptide derivative substance P antagonist biosynthetic products thereof, and process for preparation thereof. US Patent 5,338,845 dated Aug 16 1994
Sedlock DM, et al. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. I. Fermentation and isolation. J. Antibiot. 47: 391-398, 1994. PubMed: 7515037
Oleynek JJ, et al. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity. J. Antibiot. 47: 399-410, 1994. PubMed: 7515038
Popp JL, et al. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. III. Biosynthetic analogs [published erratum appears in J. Antibiot. (Tokyo) 47: C-5, 1994]. J. Antibiot. 47: 411-419, 1994. PubMed: 7515039
